INO · Inovio Pharmaceuticals, Inc. · Documents
$1.29
+0.01 (+0.78%)
At close · Sep 11
View the 10-K filed Mar 12, 2026
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not currently have sufficient working capital to fund our planned operations for the next twelve months and substantial doubt exists as to our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Customer concentration
— key customers 100% of revenue
Key customers — 100% of revenue (the years ended December 31, 2025 and 2024)
“During the years ended December 31, 2025 and 2024, we derived 100% of our revenue from ApolloBio.”
Market Cap
$132.35M
Shares
103.40M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-12 | — | |
| 8-K | 2026-07-31 | 2026-07-29 | |
| 8-K | 2026-07-29 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-05-20 | 2026-05-19 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| DEF 14A | 2026-04-07 | 2026-05-20 | |
| 8-K | 2026-04-06 | 2026-04-02 | |
| 8-K | 2026-04-02 | 2026-04-01 | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2025-12-29 | — | |
| 8-K | 2025-11-12 | 2025-11-11 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-07-07 | 2025-07-02 | |
| 8-K | 2025-05-22 | 2025-05-20 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-04-07 | 2025-05-20 | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2024-12-16 | 2024-12-12 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-05-28 | 2024-05-21 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-04-17 | 2024-04-15 | |
| DEF 14A | 2024-04-11 | 2023-12-31 | |
| 10-K | 2024-03-06 | 2023-12-31 | |
| 8-K | 2024-01-25 | 2024-01-24 | |
| 8-K | 2024-01-12 | — | |
| DEF 14A | 2023-11-28 | 2024-01-12 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-11-02 | 2023-11-01 | |
| 8-K | 2023-10-10 | — | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-09 | — | |
| 8-K | 2023-08-01 | 2023-07-31 | |
| 8-K | 2023-06-23 | — |
Showing 1–50 of 99 filings
Key facts
CIK
1055726
CUSIP
45773H409
13F (30d)
61 filings
61 filers
Visit website
Investor relations